IMH1 Antibody

What is IMH1 and what cellular functions does it regulate?

IMH1 (Imh1p in yeast) is a golgin protein that localizes to the trans-Golgi network (TGN) through interaction of its GRIP domain with GTP-bound Arl1p . IMH1 plays multiple regulatory roles in cells, including:

• Modulating spatial inactivation of Arl1p through competitive binding with Gcs1p, an Arl1p GTPase-activating protein (GAP)

• Functioning in SNARE-recycling transport pathways, particularly during ER stress conditions

• Acting as a feedback regulator to modulate GTP hydrolysis of Arl1p

• Working downstream of the Arl1-Imh1 axis to regulate SNAREs such as Tlg1 and Snc1

IMH1's N-terminal region, particularly the first five amino acids, is critical for its function in mediating proper SNARE recycling during tunicamycin (TM)-induced ER stress .

What are the key considerations for selecting an anti-IMH1 primary antibody?

When selecting an anti-IMH1 primary antibody for research applications, researchers should consider:

• Specificity: The antibody should recognize IMH1 with minimal cross-reactivity to other golgins or related proteins

• Epitope recognition: Depending on the research question, antibodies targeting different domains of IMH1 (GRIP domain, N-terminus, coiled-coil regions) may be required

• Host species: Consider compatibility with other antibodies for co-labeling experiments

• Purification method: Antigen affinity-purified polyclonal antibodies generally require lower working dilutions than monoclonal antibodies

• Validated applications: Ensure the antibody has been validated for your intended application (Western blot, immunofluorescence, immunoprecipitation)

For studying IMH1's interaction with Arl1p, antibodies recognizing the GRIP domain would be most appropriate, while research on SNARE recycling might benefit from antibodies targeting the N-terminal region .

How can IMH1 antibodies be optimized for immunofluorescence visualization of Golgi dynamics?

Optimizing IMH1 antibodies for immunofluorescence requires careful consideration of several experimental parameters:

• Fixation protocol: For Golgi proteins, 4% paraformaldehyde fixation for 15-20 minutes at room temperature typically preserves Golgi structure while allowing antibody accessibility

• Permeabilization method: Use 0.1-0.2% Triton X-100 or 0.05% saponin for balanced permeabilization that maintains Golgi integrity

• Antibody dilution: Empirically determine optimal concentration through titration experiments (typically 1:100-1:500 for commercial antibodies)

• Incubation conditions: Longer incubations (overnight at 4°C) often yield better signal-to-noise ratios

• Co-labeling strategy: Pair IMH1 antibodies with established Golgi markers (e.g., Sec7 for late-Golgi in yeast)

For dynamic studies, researchers can monitor IMH1 localization under normal versus ER stress conditions, as IMH1 shows distinctive Golgi localization patterns that change during stress response . Comparing wild-type IMH1 with mutants (particularly N-terminal deletions or mutations) can provide insights into functional domains .

What controls should be included when validating IMH1 antibody specificity?

A comprehensive validation strategy for IMH1 antibodies should include:

For IMH1-specific experiments, comparing wild-type cells with imh1Δ cells under both normal and ER stress conditions provides critical validation of antibody specificity in different experimental contexts .

How does IMH1 participate in SNARE recycling during ER stress?

IMH1 plays a central role in orchestrating SNARE recycling during ER stress through a sequential recruitment mechanism:

• IMH1 localizes to the late-Golgi through its interaction with Arl1

• The N-terminus of IMH1 (particularly the first five amino acids) is critical for recruiting Tlg2 to the late-Golgi during ER stress

• Tlg2 is then required for the recruitment of Sft2 to the late-Golgi

• Sft2 subsequently facilitates the proper localization of Tlg1

• Tlg1, in turn, enables Snc1 exocytosis and recycling

This sequential recruitment (IMH1→Tlg2→Sft2→Tlg1→Snc1) is specifically activated during ER stress conditions, suggesting IMH1 participates in stress-adaptive vesicular transport mechanisms . Deletion of IMH1 (imh1Δ) leads to mislocalization of SNAREs under ER stress but not under normal growth conditions, highlighting its stress-specific function .

What experimental approaches can distinguish between direct and indirect interactions of IMH1 with SNAREs?

To determine whether IMH1 directly interacts with SNAREs or functions through intermediate proteins like Sft2, researchers can employ:

• Co-immunoprecipitation with controls: Compare wild-type and mutant IMH1 (e.g., dN5, F2A) for their ability to co-precipitate with different SNAREs

• Yeast two-hybrid assays: Test direct interactions between IMH1 and various SNAREs or intermediary proteins

• Proximity labeling approaches: Use BioID or APEX2 fused to IMH1 to identify proximal proteins in living cells

• Sequential knockout analysis: Systematically examine protein localization in single and double knockout backgrounds (e.g., imh1Δ, sft2Δ, tlg2Δ)

• In vitro binding assays: Use purified recombinant proteins to test direct interactions

• Fluorescence resonance energy transfer (FRET): Measure protein-protein proximity in intact cells

Research using these approaches has revealed that IMH1 likely interacts indirectly with Tlg1/Snc1 SNAREs through the intermediary protein Sft2, which functions downstream of the Arl1-IMH1 axis .

How can researchers investigate the role of IMH1's N-terminus in stress-responsive SNARE regulation?

The N-terminus of IMH1, particularly the first five amino acids, is critical for its function during ER stress . To investigate this domain:

• Mutagenesis approach: Generate IMH1 variants with:

  • Deletion of the first five amino acids (IMH1 dN5)

  • Point mutations of conserved residues (e.g., F2A mutation)

  • Systematic alanine scanning of the N-terminal region

• Functional assays: Assess the ability of IMH1 variants to:

  • Restore SNARE localization in imh1Δ cells under ER stress

  • Interact with Tlg2 through co-immunoprecipitation

  • Rescue growth defects in stress-sensitive strains

• Localization studies: Compare Golgi localization patterns of:

  • Wild-type IMH1 versus mutant variants

  • Downstream factors (Sft2, Tlg1, Snc1) in the presence of IMH1 variants

• Structure-function analysis: Use structural prediction tools to identify potential binding motifs within the N-terminal region for rational design of additional mutations

Research has shown that both the dN5 deletion and F2A point mutation impair IMH1's ability to restore proper Sft2 localization in tunicamycin-treated imh1Δ cells, highlighting the importance of this region in stress response signaling .

What approaches can determine whether IMH1 antibodies detect different conformational states of the protein?

IMH1 may adopt different conformational states depending on its interaction partners or stress conditions. To investigate this:

• Epitope-specific antibody panels: Generate or obtain antibodies targeting different domains of IMH1 and compare their staining patterns under various conditions

• Conformational-specific antibody development: Isolate antibodies that preferentially recognize:

  • GTP-bound Arl1-associated IMH1

  • IMH1 involved in SNARE complexes

  • Stress-activated IMH1 conformations

• Comparative immunoprecipitation: Use different antibodies to immunoprecipitate IMH1 and analyze co-precipitating partners by mass spectrometry

• FRET-based biosensors: Develop IMH1 conformational sensors using fluorescent protein pairs to monitor structural changes in living cells

• Limited proteolysis assays: Compare proteolytic susceptibility of IMH1 under different conditions to identify conformational changes

These approaches would help determine whether IMH1 antibodies can distinguish between functionally relevant states of the protein, potentially revealing mechanisms of regulation not apparent from localization studies alone.

How does IMH1 modulate Arl1p activity through competitive interactions with GAPs?

IMH1 functions as a feedback regulator of Arl1p activity through competitive binding with the GAP protein Gcs1p:

• IMH1 competes with Gcs1p (an Arl1p GAP) for binding to Arl1p, thus interfering with Gcs1p's GAP activity toward Arl1p

• Self-interaction of IMH1 attenuates Gcs1p-dependent GTP hydrolysis of Arl1p

• Deletion of IMH1 (imh1Δ) in yeast decreases the amount of GTP-bound Arl1p and reduces Arl1p residence at the TGN

This competitive interaction creates a regulatory feedback loop where IMH1, recruited by active GTP-bound Arl1p, subsequently protects Arl1p from inactivation by Gcs1p. This mechanism helps maintain a pool of active Arl1p at the TGN, which is necessary for proper Golgi function .

What experimental strategies can differentiate the roles of IMH1 in steady-state versus stress-induced vesicular transport?

To distinguish between IMH1's constitutive and stress-induced functions:

• Temporal analysis: Compare IMH1-dependent protein localization:

  • Before stress induction (baseline)

  • During acute stress (early response)

  • During prolonged stress (adaptive response)

  • After stress resolution (recovery phase)

• Cargo-specific trafficking assays: Monitor transport of:

  • Constitutive secretory cargoes (e.g., invertase)

  • Stress-responsive cargoes (e.g., chaperones)

  • Recycling membrane proteins (e.g., Snc1)

• Stress-specific IMH1 mutants: Generate and characterize:

  • Mutations affecting only stress-responsive functions (e.g., N-terminal mutants)

  • Mutations affecting constitutive functions

• Quantitative microscopy: Measure:

  • Colocalization coefficients between IMH1 and different markers

  • Residence times of IMH1 at different compartments

  • Mobility of IMH1 using FRAP (Fluorescence Recovery After Photobleaching)

Research has shown that while Snc1/Tlg1 SNAREs display proper localization in both wild-type and imh1Δ cells under normal growth conditions, they exhibit mislocalization in imh1Δ cells specifically during tunicamycin-induced ER stress, indicating a stress-specific function .

How might research on antibody immunodominance inform the development of new anti-IMH1 antibodies?

Studies on antibody immunodominance can provide insights for developing improved anti-IMH1 antibodies:

• Antibody responses to proteins are often hierarchical, with certain epitopes eliciting stronger responses than others (immunodominance)

• This hierarchy is influenced by epitope accessibility, stability, and conformational properties rather than simply protein abundance

• The immunodominance of B cell responses varies between individuals, with some individuals focusing heavily on single antigenic sites

For IMH1 antibody development, researchers could:

• Map immunodominant epitopes across the IMH1 protein structure

• Design immunogens that expose normally subdominant but functionally informative epitopes

• Screen antibody libraries for rare clones that recognize functionally critical regions

• Use rational immunogen design to target specific domains (e.g., the N-terminal region critical for stress response)

Understanding immunodominance patterns could help develop antibody panels that collectively provide more comprehensive information about IMH1 conformations and interactions.

What are the key methodological considerations for studying IMH1 in different model organisms?

IMH1 (or its homologs) can be studied across different model systems, each requiring specific methodological adaptations:

When adapting research across different model systems, researchers should:

• Identify the appropriate ortholog of IMH1 through sequence and functional analysis

• Validate antibody specificity in each model organism

• Establish equivalent stress induction protocols for comparative studies

• Consider species-specific differences in Golgi organization and dynamics

The yeast model has been particularly valuable for elucidating IMH1's role in the sequential recruitment of Tlg2→Sft2→Tlg1→Snc1 during ER stress .